Nanomedicine News

RSS

Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals

NanoViricides, Inc., (the "Company"), a nanomedicine company developing anti-viral drugs, reports dramatic improvement in clinical symptoms associated with herpes simplex virus infection in the recently completed studies in mice. The studies were performed in the laboratory of Dr. Ken S. Rosenthal at Northeast Ohio Medical University where Dr. Rosenthal is now Professor Emeritus. He is a leading researcher in herpes virus anti-viral agents and vaccines.

From NanoViricides, Inc 21 Apr 2015

Easy, Effective Method to Fasten Proteins to Nanoparticles for Cancer Treatment

Fastening protein-based medical treatments to nanoparticles isn't easy.

21 Apr 2015

Lab-on-a-Chip Device for Rapid Diagnosis of Cryptosporidium Infections

For a healthy individual, an infection of Cryptosporidium parvum may mean nothing more than a few days of bad diarrhea. For someone with a compromised immune system, it can mean death, following an excruciating, protracted bout of watery diarrhea.

16 Apr 2015

InMed Receives Mitacs Grant to Further Develop Nanoparticle-Based Drug Delivery System for Glaucoma

InMed Pharmaceuticals Inc., a clinical stage biopharmaceutical company that specializes in developing safer, more effective cannabinoid-based therapies, today announced that it has been awarded a grant to further develop the Company's proprietary nanoparticle-based delivery system for their leading drug candidate CTI-085 for glaucoma.

16 Apr 2015

CEO of Cerulean Presents at Needham Healthcare Conference

Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference on Wednesday, April 15th at 5:00 p.m. ET in New York.

16 Apr 2015

New Global Nanomedicine Market & Pipeline Insight 2015 Report

Research and Markets has announced the addition of the "Global Nanomedicine Market & Pipeline Insight 2015" report to their offering.

15 Apr 2015

Gold Nanoparticles Tethered to pHLIPs Increase Effectiveness of Cancer-Killing Radiation

Researchers from Brown University and the University of Rhode Island have demonstrated a promising new way to increase the effectiveness of radiation in killing cancer cells.

15 Apr 2015

Iron Nanoparticles Heated at Precise Temperatures May Help Treat Tumors

Seeking a way to stimulate antitumor responses via the immune system, Steven Fiering, PhD, of Norris Cotton Cancer Center at Dartmouth, has identified the precise temperature that results in a distinct body-wide antitumor immune response that resists metastatic disease.

15 Apr 2015

Tekmira's TKM-Ebola IND Modified by FDA to Allow Repeat Dosing of Healthy Volunteers

Tekmira Pharmaceuticals Corporation, an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), announced today that the U.S. Food and Drug Administration (FDA) has notified the Company that the partial clinical hold on the company's Investigational New Drug application (IND) for TKM-Ebola has been modified to permit repeat dosing of healthy volunteers at a dose of 0.24 mg/kg/day. The IND remains on partial clinical hold with regard to doses above 0.24 mg/kg/day in healthy volunteers.

13 Apr 2015

Dicerna Announces Promising Data for CTNNB1 DsiRNA in Multiple Patient-Derived Xenograft Tumor Types

Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today announced promising new in vivo data for CTNNB1 DsiRNA in multiple patient-derived xenograft (PDX) and other models of diverse tumor types. CTNNB1 DsiRNA is an extended Dicer substrate short interfering RNA (DsiRNA-EX) therapeutic targeting â-catenin delivered using Dicerna’s proprietary next generation EnCore™ lipid nanoparticle (LNP) technology.

13 Apr 2015

Nanomedicine News

Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals

Easy, Effective Method to Fasten Proteins to Nanoparticles for Cancer Treatment

Lab-on-a-Chip Device for Rapid Diagnosis of Cryptosporidium Infections

InMed Receives Mitacs Grant to Further Develop Nanoparticle-Based Drug Delivery System for Glaucoma

CEO of Cerulean Presents at Needham Healthcare Conference

New Global Nanomedicine Market & Pipeline Insight 2015 Report

Gold Nanoparticles Tethered to pHLIPs Increase Effectiveness of Cancer-Killing Radiation

Iron Nanoparticles Heated at Precise Temperatures May Help Treat Tumors

Tekmira's TKM-Ebola IND Modified by FDA to Allow Repeat Dosing of Healthy Volunteers

Dicerna Announces Promising Data for CTNNB1 DsiRNA in Multiple Patient-Derived Xenograft Tumor Types

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials